| For: | Ji FP, Li ZX, Deng H, Xue HA, Liu Y, Li M. Diagnosis and management of interstitial pneumonitis associated with interferon therapy for chronic hepatitis C. World J Gastroenterol 2010; 16(35): 4394-4399 [PMID: 20845505 DOI: 10.3748/wjg.v16.i35.4394] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i35/4394.htm |
| Number | Citing Articles |
| 1 |
Syeda Zainab Ilyas, Rabia Tabassum, Haroon Hamed, Shafiq Ur Rehman, Ishtiaq Qadri. Hepatitis C Virus-Associated Extrahepatic Manifestations in Lung and Heart and Antiviral Therapy-Related Cardiopulmonary Toxicity. Viral Immunology 2017; 30(9) doi: 10.1089/vim.2017.0009
|
| 2 |
Bing Tian, Pan Wang, Chun Shan, Cheng Gao, Qun Zhang. Organizing pneumonia in a patient following treatment of chronic hepatitis B with pegylated interferon alfa-2b: A case report. IDCases 2025; 39 doi: 10.1016/j.idcr.2025.e02191
|
| 3 |
Jun‐Kyoung Lee, Jung‐Hoon Kim, Hyeun Kyoo Shin. Therapeutic effects of the oriental herbal medicine Sho‐saiko‐to on liver cirrhosis and carcinoma. Hepatology Research 2011; 41(9) doi: 10.1111/j.1872-034X.2011.00829.x
|
| 4 |
Ernesta Bagurskienė, Rolandas Zablockis. ORGANIZUOJANTI PNEUMONIJA. KLINIKINIS ATVEJIS. Visuomenės sveikata 2018; 28(5) doi: 10.5200/sm-hs.2018.061
|
| 5 |
Laurent Savale, Caroline Sattler, Sven Günther, David Montani, Marie-Camille Chaumais, Swanny Perrin, Xavier Jaïs, Andrei Seferian, Roland Jovan, Sophie Bulifon, Florence Parent, Gérald Simonneau, Marc Humbert, Olivier Sitbon. Pulmonary arterial hypertension in patients treated with interferon. European Respiratory Journal 2014; 44(6) doi: 10.1183/09031936.00057914
|
| 6 |
Vinod S. Hegade, Ruchit Sood, Dinesh Saralaya, Sulleman Moreea. Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-Two case reports. Annals of Hepatology 2013; 12(4) doi: 10.1016/S1665-2681(19)31348-1
|
| 7 |
Peter M. George, Morven E. Cunningham, Neil Galloway‐Phillipps, Rekha Badiger, William Alazawi, Graham R. Foster, Jane A. Mitchell. Endothelin‐1 as a Mediator and Potential Biomarker for Interferon Induced Pulmonary Toxicity. Pulmonary Circulation 2012; 2(4) doi: 10.4103/2045-8932.105039
|
| 8 |
Hanyu Zhang, Miaorong Xie. Acute interstitial pneumonia caused by interleukin-2 and interferon α-2b therapy for renal cell carcinoma: a case report and clinical study. Chinese Medical Journal 2014; 127(23) doi: 10.3760/cma.j.issn.0366-6999.20141585
|
| 9 |
Peter M. George, Rekha Badiger, William Alazawi, Graham R. Foster, Jane A. Mitchell. Pharmacology and therapeutic potential of interferons. Pharmacology & Therapeutics 2012; 135(1) doi: 10.1016/j.pharmthera.2012.03.006
|
| 10 |
Shin Takayama, Tetsuya Akaishi, Masakazu Hanagama, Yuko Itakura, Ryutaro Arita, Akiko Kikuchi, Tadashi Ishii. Herbal medicine-induced multiple pulmonary pseudotumors. Journal of Family Medicine and Primary Care 2020; 9(7) doi: 10.4103/jfmpc.jfmpc_420_20
|
| 11 |
Vasiliki Georgakopoulou, Stavroula Asimakopoulou, Evangelos Cholongitas. Pulmonary function testing in patients with liver cirrhosis (Review). Medicine International 2023; 3(4) doi: 10.3892/mi.2023.96
|